Marketing-authorisation holder
Blue Earth Diagnostics Ireland Limited
6 medicines in 4 countries, as authorisation holder and marketer.
Loading your page…
Marketing-authorisation holder
6 medicines in 4 countries, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Axumin | Fluciclovine (18f) | EU (EMA) | Authorised | 2017 |
| AXUMINSoluzione iniettabile | Fluciclovine (18f) | Italy | Authorised | |
| Axumin 1600 MBq/ml oplossing voor injectieOplossing voor injectie | Fluciclovine (18f) | Netherlands | Authorised | 2017 |
| AXUMIN 1600 MBq/ML SOLUCION INYECTABLE1600 megabecquerelio · Solución inyectable | Fluciclovine (18f) | Spain | Authorised | 2018 |
| Axumin 3200 MBq/ml oplossing voor injectieOplossing voor injectie | Fluciclovine (18f) | Netherlands | Authorised | 2017 |
| AXUMIN 3200 MBq/ML SOLUCION INYECTABLE3200 megabecquerelio · Solución inyectable | Fluciclovine (18f) | Spain | Authorised | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 2 | 2 | 0 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
| Italy | 1 | 1 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.